Your browser doesn't support javascript.
loading
Insights into the roles and driving forces of CCT3 in human tumors.
Ma, Jingang; Song, Ping; Liu, Xinling; Ma, Changgeng; Zheng, Mingzhu; Ren, Xiaomin; Wang, Rui; Liu, Wenshan; Lu, Zhong; Li, Jiaqiu.
Afiliação
  • Ma J; Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
  • Song P; Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Medical School of Zhejiang University, Hangzhou, China.
  • Liu X; Department of Hematology, Laboratory for Stem Cell and Regenerative Medicine, Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Ma C; Department of Radiotherapy, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Zheng M; Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
  • Ren X; Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
  • Wang R; Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
  • Liu W; Shandong Key Laboratory of Clinical Applied Pharmacology, Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Lu Z; Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
  • Li J; Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
Front Pharmacol ; 13: 1005855, 2022.
Article em En | MEDLINE | ID: mdl-36313331

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China